Outpatient Treatment for Late Stage Cancer
Cancer is just an ailment, we treat it like one
Efficient and Timely
Fast acting and effective treatment course allows patients to receive effective treatment in any cancer stage and recover within weeks of receiving treatment
Environmentally Friendly
With the elimination of chemotherapy supplies, we reduce the global radioactive pollution caused by mishandling of the toxic waste
Universal Application
Proprietary Nano-technology allows use of one treatment type for multiple types of cancer, lowering overall costs for patients and establishments
An early diagnosis is the difference between a normal life and a prolonged, painful death. Early detection and diagnosis is the most crucial part of survival, however, the less survivable a cancer type is, the later it is diagnosed.
It is nearly impossible to avoid late stage cancer diagnostics, but it is very possible to provide effective and definite treatment plans to patients. According to Cancer Research UK, patients with less survivable cancers have a survival rate of 16%. Putting that into perspective, if you are diagnosed with lung, liver, brain, esophageal, pancreatic, or stomach cancer, you have better chances playing the state lottery!
Our proprietary system is designed specifically for patients with a late stage, aggressive, and lethal cancer diagnosis that will only suffer when provided the traditional treatment plans. This treatment destroys cancerous cells via mechanical principles, eliminating adaptation or further mutation of cancerous cells when they come out of remission.
Simulation-Driven Nanotechnology for Accelerated Medical Breakthroughs
Leveraging advanced simulation and computational modeling to design, optimize, and validate novel Nano-materials and devices for challenging therapeutic and diagnostic applications prior to extensive lab work, R&D timelines and costs for partner companies have been greatly reduced.
Market Share and Growth
With a current US market of $377BN, and exponential forecasted cancer treatment market potential, the investment criteria have never looked better.
Featured Articles
